Overexpression of a cloned IMP dehydrogenase gene of Candida albicans confers resistance to the specific inhibitor mycophenolic acid
- PMID: 9079920
- PMCID: PMC178971
- DOI: 10.1128/jb.179.7.2331-2338.1997
Overexpression of a cloned IMP dehydrogenase gene of Candida albicans confers resistance to the specific inhibitor mycophenolic acid
Abstract
An IMP dehydrogenase gene was isolated from Candida albicans on a approximately 2.9-kb XbaI genomic DNA fragment. The putative Candida IMP dehydrogenase gene (IMH3) encodes a protein of 521 amino acids with extensive sequence similarity to the IMP dehydrogenases of Saccharomyces cerevisiae and various other organisms. Like the S. cerevisiae IMH3 sequence characterized in the genome sequencing project, the open reading frame of the C. albicans IMH3 gene is interrupted by a small intron (248 bp) with typical exon-intron boundaries and a consensus S. cerevisiae branchpoint sequence. IMP dehydrogenase mRNAs are detected in both the yeast and hyphal forms of C. albicans as judged by Northern hybridization. Growth of wild-type (sensitive) C. albicans cells is inhibited at 1 microg of mycophenolic acid (MPA), a specific inhibitor of IMP dehydrogenases, per ml, whereas transformants hosting a plasmid with the IMH3 gene are resistant to MPA levels of up to at least 40 microg/ml. The resistance of cells to MPA is gene dosage dependent and suggests that IMH3 can be used as a dominant selection marker in C. albicans.
Similar articles
-
Single-copy IMH3 allele is sufficient to confer resistance to mycophenolic acid in Candida albicans and to mediate transformation of clinical Candida species.Infect Immun. 2001 Jan;69(1):108-14. doi: 10.1128/IAI.69.1.108-114.2001. Infect Immun. 2001. PMID: 11119495 Free PMC article.
-
Shuttle vectors for Candida albicans: control of plasmid copy number and elevated expression of cloned genes.Curr Genet. 2004 Jun;45(6):390-8. doi: 10.1007/s00294-004-0499-3. Epub 2004 Mar 18. Curr Genet. 2004. PMID: 15034753
-
Direct transformation of a clinical isolate of Candida parapsilosis using a dominant selection marker.FEMS Microbiol Lett. 2005 Apr 1;245(1):117-21. doi: 10.1016/j.femsle.2005.02.035. FEMS Microbiol Lett. 2005. PMID: 15796988
-
Molecular characterization of IMP dehydrogenase in acquired resistance to mycophenolic acid.Adv Exp Med Biol. 1994;370:725-8. doi: 10.1007/978-1-4615-2584-4_151. Adv Exp Med Biol. 1994. PMID: 7661007 Review. No abstract available.
-
Human type I and II IMP dehydrogenases as drug targets.Ann N Y Acad Sci. 1993 Nov 30;696:88-93. doi: 10.1111/j.1749-6632.1993.tb17144.x. Ann N Y Acad Sci. 1993. PMID: 7906497 Review. No abstract available.
Cited by
-
Csr1/Zap1 Maintains Zinc Homeostasis and Influences Virulence in Candida dubliniensis but Is Not Coupled to Morphogenesis.Eukaryot Cell. 2015 Jul;14(7):661-70. doi: 10.1128/EC.00078-15. Epub 2015 May 22. Eukaryot Cell. 2015. PMID: 26002718 Free PMC article.
-
Generation of Viable Candida albicans Mutants Lacking the "Essential" Protein Kinase Snf1 by Inducible Gene Deletion.mSphere. 2020 Aug 19;5(4):e00805-20. doi: 10.1128/mSphere.00805-20. mSphere. 2020. PMID: 32817381 Free PMC article.
-
Tec1p-independent activation of a hypha-associated Candida albicans virulence gene during infection.Infect Immun. 2004 Apr;72(4):2386-9. doi: 10.1128/IAI.72.4.2386-2389.2004. Infect Immun. 2004. PMID: 15039365 Free PMC article.
-
MDR1-mediated drug resistance in Candida dubliniensis.Antimicrob Agents Chemother. 2001 Dec;45(12):3416-21. doi: 10.1128/AAC.45.12.3416-3421.2001. Antimicrob Agents Chemother. 2001. PMID: 11709317 Free PMC article.
-
A structural determinant of mycophenolic acid resistance in eukaryotic inosine 5'-monophosphate dehydrogenases.Protein Sci. 2020 Mar;29(3):686-694. doi: 10.1002/pro.3766. Epub 2019 Nov 20. Protein Sci. 2020. PMID: 31675145 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases